The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
Authors
Keywords
Helicobacter pylori, Antibiotic resistance, Adverse events, Endoscopy, Antibiotics, Antimicrobial resistance, Biopsy, Peptic ulcers
Journal
PLoS One
Volume 9, Issue 8, Pages e105822
Publisher
Public Library of Science (PLoS)
Online
2014-08-21
DOI
10.1371/journal.pone.0105822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment ofHelicobacter pyloriInfection 2013
- (2013) Anthony O'Connor et al. HELICOBACTER
- Ten-Day Quadruple Therapy Comprising Proton-Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate forHelicobacter pyloriInfection after Failure of Sequential Therapy
- (2013) Ping-I Hsu et al. HELICOBACTER
- Antibiotic Resistance ofHelicobacter PyloriIsolated in the Southeast Coastal Region of China
- (2013) Peng Su et al. HELICOBACTER
- Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan
- (2013) Kazunari Murakami et al. JOURNAL OF GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial
- (2012) C.-H. Kuo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
- (2012) J.-M. Liou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
- (2012) Javier P. Gisbert et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The Effect of Bulgecin A on Peptidoglycan Metabolism and Physiology of Helicobacter pylori
- (2012) Mathilde Bonis et al. Microbial Drug Resistance
- Rescue Therapy forHelicobacter pyloriInfection 2012
- (2012) Javier P. Gisbert Gastroenterology Research and Practice
- Distribution of SpontaneousgyrAMutations in 97 Fluoroquinolone-Resistant Helicobacter pylori Isolates Collected in France
- (2011) Magali Garcia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection
- (2011) Stephan Miehlke et al. HELICOBACTER
- High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia
- (2011) Khean-Lee Goh et al. HELICOBACTER
- Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days
- (2011) Ping-I. Hsu et al. HELICOBACTER
- A new look at anti-Helicobacter pylori therapy
- (2011) Seng-Kee Chuah WORLD JOURNAL OF GASTROENTEROLOGY
- Contribution of Specific Amino Acid Changes in Penicillin Binding Protein 1 to Amoxicillin Resistance in ClinicalHelicobacter pyloriisolates
- (2010) Nadia N. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotypic Resistance inHelicobacter pyloriStrains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies
- (2010) Jyh-Ming Liou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori
- (2009) E. Cambau et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection
- (2009) K Ming Fock et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
- (2007) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started